Mutations and changes in a protein's environment are well characterized for their potential to induce misfolding and aggregation, including amyloid formation. Alternatively, such perturbations can trigger new interactions leading to the polymerization of folded proteins. In contrast to aggregation, this process does not require misfolding and to mark this difference, we refer to it as agglomeration. This term encompasses the amorphous assembly of folded proteins as well as their folded-state polymerization in one-, two-, or three-dimensions. We stress the remarkable potential of symmetric homo-oligomers to agglomerate even by single surface point mutations, and we review the double-edged nature of this potential: how aberrant assemblies resulting from agglomeration can lead to disease, but also how agglomeration can serve in cellular adaptation and be exploited for the rational design of novel biomaterials.